Skip to main content
PLOS One logoLink to PLOS One
. 2021 Sep 3;16(9):e0256955. doi: 10.1371/journal.pone.0256955

Prevalence and correlates of voluntary medical male circumcision adverse events among adult males in the Copperbelt Province of Zambia: A cross-sectional study

Imukusi Mutanekelwa 1, Seter Siziya 1, Victor Daka 1,2,*, Elijah Kabelenga 3, Ruth L Mfune 1,2, Misheck Chileshe 4, David Mulenga 1, Herbert Tato Nyirenda 1, Christopher Nyirenda 1, Steward Mudenda 2,5, Bright Mukanga 1, Kasonde Bowa 6
Editor: Richard Kao Lee7
PMCID: PMC8415607  PMID: 34478471

Abstract

Background

Voluntary Medical Male Circumcision (VMMC) is a key intervention in HIV/AIDS. Improving VMMC program uptake in Zambia requires careful monitoring of adverse events (AE) to inform program quality and safety. We investigate the prevalence of VMMC AE and their associated factors among adult males in Ndola, Copperbelt Province, Zambia.

Methods

We performed a cross-sectional study using secondary clinical data collected in 2015 using two validated World Health Organisation/Ministry of Health reporting forms. We reviewed demographics and VMMC surgical details from 391 randomly sampled adult males aged ≥18 years at Ndola Teaching Hospital, a specialised VMMC fixed site in Zambia. Non-parametric tests (Fisher’s exact test or Chi-square depending on assumptions being met) and logistic regression were conducted to determine the relationships between associated factors and VMMC AE.

Results

The overall VMMC AE prevalence was 3.1% (95% CI 1.60%– 5.30%) and most AEs occurred postoperatively. In decreasing order, the commonly reported VMMC AE included; bleeding (47.1%), swelling (29.4%), haematoma (17.6%), and delayed wound healing (5.9%). There was an inversely proportional relationship between VMMC volume (as measured by the number of surgeries conducted per VMMC provider) and AEs. Compared to the highest VMMC volume of 63.2% (247/391) as reference, as VMMC volume reduced to 35.0% (137/391) and then 1.8% (7/391), the likelihood of AEs increased by five times (aOR 5.08; 95% CI 1.33–19.49; p = 0.018) and then sixteen times (aOR 16.13; 95% CI 1.42–183.30; p = 0.025) respectively.

Conclusions

Our study found a low prevalence of VMMC AEs in Ndola city, Copperbelt Province of Zambia guaranteeing the safety of the VMMC program. We recommend more surgically proficient staff to continue rendering this service. There is a need to explore other high priority national/regional areas of VMMC program safety/quality, such as adherence to follow-up visits.

Introduction

Voluntary Medical Male Circumcision (VMMC) is a key intervention in HIV/AIDS [1]. Since 2007, VMMC has been recommended by WHO/UNAIDS as efficacious for the prevention of HIV in a country such as Zambia which has heterosexual epidemics, low VMMC, and high HIV prevalence [1, 2]. Evidence from randomised clinical trials (RCT) have shown VMMC to provide 60% partial protection by reducing the risk of acquiring HIV in heterosexual men [35] with the level of protection increasing to 74% over time [6]. In contrast to Northern Africa where traditional circumcision is practiced extensively, VMMC practice is rare in Sub-Saharan Africa (SSA), an area disproportionately affected by HIV/AIDS [7]. For instance, Zambia still has one of the highest HIV prevalence rates in SSA [8].

The World Health Organisation (WHO) recommends the scale-up of VMMC in low Male Circumcision and high HIV prevalence countries of SSA with careful monitoring of adverse events which are not to exceed 5% [9]. However, the reported VMMC adverse events (AE) estimates range from 1.0–6% [35, 1013] with the lowest AE rates seen intraoperatively with a prevalence between 0.1% - 0.2% [10, 14]. In ascending order, the prevalence of VMMC adverse event in various SSA countries was as follows: 1.0% South Africa [3], 1.5% Kenya [4], 2.0 Kenya [11], 2.2% Kenya [10], 3.6% Uganda [5], 5.1% Kenya [13], and 5.47% Uganda [12]. One of the main WHO monitoring and evaluation parameters is the number or percentage of circumcised males experiencing an adverse event during and after the VMMC procedure [15]. This parameter is important because it provides information to determine the overall safety/quality of a VMMC program, which also influences an individual’s perceived safety concerns and ultimately affects VMMC coverage [15]. According to the Zambia National VMMC operational plan 2016–2020, studies concerning VMMC adverse events is a research priority at the national and regional level to improve the quality of the VMMC program [16]. There has been paucity of data and little published work on the demand-side factors affecting the VMMC coverage such as safety/quality of the VMMC and adverse events in Zambia. The current study attempts to redress this critical knowledge gap. The objective of the study was to determine the prevalence of VMMC adverse events among adult males in Ndola on the Copperbelt Province of Zambia using a cross-sectional study design.

Materials and methods

Study design

We conducted a cross-sectional study using secondary clinical data collected from January to December 2015 at Ndola Teaching Hospital in Copperbelt Province of Zambia. Ndola Teaching Hospital is a third level specialised referral healthcare facility which is the largest in the northern region of Zambia [17]. The hospital is a fixed VMMC site and during school holidays adopts a campaign VMMC model. A VMMC campaign model involves actively mobilising pupils and conducting VMMC during the school holidays to avoid disruption of learning time [16]. At the hospital, conventional surgery is employed for VMMC as medical devices are not stocked nor used. Though conventional surgery can be done by one of three methods (Dorsal Slit, Sleeve, or Forceps Guided), WHO recommends forceps guided technique to be used [9]. The hospital is responsible for the seven core VMMC responsibilities, serves as a clinical training hub for the lower levels, and is a referral centre when AEs need specialised attention. The seven core components of VMMC include registration/waiting, group education, individual HIV testing/counselling, clinical screening, VMMC surgery, immediate postoperative care, and lastly postoperative follow up care.

Sample size estimation

The sample size estimation was based on the prevalence of VMMC AE of 8% obtained from a previous study done in neighbouring Malawi because of similarities in VMMC training and reporting guidelines [18]. Employing a precision of 3% and accounting for a 20% missing clinical information, a minimum sample size of 377 adult males was determined. However, a total of 391 records which met the inclusion criteria were available and included in the study. The inclusion criteria were adult males aged 18 years and above who underwent VMMC at Ndola Teaching Hospital in 2015, while males less than 18 years were excluded from the study.

Sources of secondary data

This study used secondary VMMC clinical data collected at Ndola Teaching Hospital from January to December 2015. The hospital recorded the VMMC details and outcomes using two WHO/Ministry of Health validated reporting forms which researchers accessed to collect the data. The first form accessed by researchers was called the ’VMMC client record form’ and data were collected for each adult male sampled. Researchers reviewed the second form called the ’VMMC Adverse Events form’ for the few adult males who experienced adverse events as this form is not available when an adverse event has not occurred. The ’VMMC client record form’ provided information such as sociodemographic characteristics, history taken, physical examination details, investigations conducted, surgical operation details (pre-op preparation, procedure type, duration, provider, outcome), and follow-up visits. If an adverse event occurred, the VMMC provider initially records it in the ’VMMC client record form’ however with fewer details as most details are made available in the ’VMMC Adverse Events form’. The ’VMMC Adverse Events form’, is only used when an adverse event has occurred, and it provides detailed information regarding the type of adverse event, severity (mild, moderate or severe), treatment provided/ outcome, and the timing of the adverse event [15]. The types of VMMC adverse events in the latter form includes pain, infection, delayed wound healing, excessive bleeding, swelling/haematoma, insufficient or excessive skin removed, damage to the penis, appearance, and voiding problems.

Ethical considerations

The Biomedical Research Ethics Committee (#BE064/16) at the University of Kwazulu-Natal in South Africa approved this study. The Ndola Teaching Hospital management granted access to review clinical records. Confidentiality was maintained by not publishing unique identifiers and restricting data accessibility to the research team only.

Statistical analysis

All data were entered and analysed using Statistical Package for the Social Sciences (SPSS) v.25. The computed descriptive statistics were expressed as frequencies and tabulated. The prevalence of adverse VMMC AE was calculated with its 95% CI using the Exact method by Clopper and Pearson (1934). The relationships between predictor variables and AE were assessed using Fisher’s exact test when the test assumption of expected frequency for each cell to be at least five was not met for the use of Pearson chi-square (χ2). Binomial logistic regression using a stepwise backward elimination (likelihood ratio) method for selection of variables was employed to control for all confounders. For inclusion in the multivariate logistic regression model, variables needed a p ≤0.05 in the univariate binomial logistic regression. For both analyses, a result yielding p value < 0.05 was regarded as statistically significant. Incompletely filled in VMMC forms led to variables with missing values; missing values were handled using listwise deletion by excluding them from the analysis [19].

Results

Adverse events and sociodemographic characteristics

We reviewed a total of 391 VMMC records of participants from Ndola Teaching Hospital. The estimated overall prevalence for VMMC AE was 3.1% (95% CI 1.60%– 5.30%) in Ndola city, Copperbelt Province of Zambia. The prevalence was higher (10/391, 2.6%) in the postoperative period (see Fig 1). The commonly reported VMMC AEs during the 48 hours, 7 days and 4 weeks postoperative follow-up visit were bleeding (4/8), infection (3/7), and delayed wound healing (1) respectively (see Fig 2).

Fig 1. Prevalence and timing of VMMC AE among adult males.

Fig 1

Fig 2. Frequency and types of AE experienced during the follow-up visits.

Fig 2

There were higher proportions of AEs noted in the age group 50+ years (1/14, 7.1%) compared to the younger age group (11/377, 2.9%. The AE proportion was similar for those who were married (4/123, 3.3%) and those who were not (8/263, 3.0%). Individuals who indicated the reason for undergoing VMMC as partial protection against acquiring HIV experienced similar AE proportions (10/308, 3.3%) compared to those with other reasons (1/45, 2.2%). Furthermore, using Fisher’s exact test, reasons for undergoing VMMC and sociodemographic characteristics were not significantly associated with AEs (see Table 1).

Table 1. Prevalence of AE according to sociodemographic characteristics.

Total, n (%)* No Adverse Event Adverse Event present P value
Ages
    18–49 376 (100) 365 (97.1) 11 (2.9) 0.359
    50+ 14 (100)** 13 (92.9) 1 (7.1)
Marital Status
    Not Married 263 (100) 255 (97.0) 8 (3.0) 1.000
    Married 123 (100) 119 (96.7) 4 (3.3)
Tribe
    Bemba 139 (100) 138 (99.3) 1 (0.7) 0.063
    Non-Bemba 246 (100) 235 (99.5) 11 (4.5)
Primary Indication for MC
    Partial Protection against HIV 308 (100) 298 (96.8) 10 (3.2) 1.000
    Other 45 (100) 44 (97.8) 1 (2.2)

* Row percents.

** Interpret the percentages with caution since the denominator is less than 30.

VMMC operation details

From Table 2, regarding the VMMC volume as measured by the number of circumcisions conducted, two individual enrolled nurses completed more than half (247/391, 63.2%) followed by three individual registered nurses (137/391, 35.0%) and lastly two individual medical officers (7/391, 1.8%). The VMMC AE proportion in medical officers was one in seven (1/7, 14.3%) and for nurses (11/384, 2.9%). There were similar AE proportions noted for VMMC conducted in the first semester (5/187, 2.7%) and second semester (7/204, 3.4%) of 2015. There were variable VMMC AE proportions according to the duration of the surgery, volume of lignocaine used, VMMC type and males who attended VMMC follow-up visit. Using Fisher’s exact test, only one variable, namely VMMC volume (p = 0.008) was significantly associated with AE while all other VMMC operation factors were not (see Table 2).

Table 2. Prevalence of AE according to surgical operation details.

Total, n (%)* No Adverse Event Adverse Event present P value
VMMC Volume±, n = 391
    Enrolled Nurses (ZEN, ETN) 247 (100) 244 (98.8) 3 (1.2) 0.008
    Registered Nurses (RN, RTN, RM) 137 (100) 129 (94.2) 8 (5.8)
    Medical Officer (JRMO, Surgeon) 7 (100) ** 6 (85.7) 1 (14.3)
Date of operation, n = 391
    January–June 187 (100) 182 (97.3) 5 (2.7) 0.664***
    July–December 204 (100) 197 (96.6) 7 (3.4)
Duration, n = 347
    < 20 minutes 96 (100) 93 (96.9) 3 (3.1) 0.834
    20–30 minutes 185 (100) 179 (96.8) 6 (3.2)
    > 30 minutes 66 (100) 65 (98.5) 1 (1.5)
Local Anaesthetic amount used, n = 236 0.604
    Between 8–10 ml 188 (100) 184 (97.9) 4 (2.1)
    Below 8 or above 10 48 (100) 46 (95.8) 2 (4.2)
VMMC Type, n = 386
    Dorsal Slit 384 (100) 373 (97.1) 11 (2.9) 0.061
    Sleeve Resection 2 (100)* 1 (50.0) 1 (50.0)
Follow-up immediately post op, n = 391
    Yes 386 (100) 375 (82.4) 11 (2.8) 0.145
    No 5 (100)* 4 (80.0) 1 (20.0)
Follow-up visit at 48 hours, n = 391
    Yes 333 (100) 322 (96.7) 11 (3.3) 1.000
    No 58 (100) 57 (98.3) 1 (1.7)
Follow-up visit at 7 days, n = 391
    Yes 216 (100) 209 (96.8) 7 (3.2) 0.827***
    No 175 (100) 170 (97.1) 5 (2.9)
Follow-up visit at 4 weeks, n = 391
    Yes 61 (100) 57 (93.4) 4 (6.6) 0.100
    No 330 (100) 322 (97.6) 8 (2.4)
Follow-up at least 1 visit post VMMC, n = 391
    Yes 350 (100) 339 (96.9) 11 (3.1) 1.000
    No 41 (100) 40 (97.6) 1 (2.4)

± ZEN = Zambia Enrolled Nurse, ETN = Enrolled Theatre Nurse, RN = Registered General Nurse, RTN = Registered Theatre Nurse, RM = Registered Midwife, JRMO = Junior Resident Medical Officer.

* Row percents.

** Interpret the percentages with caution since the denominator is less than 30.

*** Chi-square was valid.

Factors associated with VMMC AE

Table 3 depicts the results of the univariate binomial regression analysis which shows the association between AE and various independent variables. Independent variables included sociodemographic factors and VMMC pre and post operation details. Only two factors were univariately associated with AEs and these were VMMC volume (as measured by the number of surgeries conducted per VMMC provider) and VMMC type. Compared to the highest VMMC volume (63.2%) as reference, as VMMC volume reduced to 35.0% and then 1.8% the likelihood of AEs increased by five times (OR 5.044; 95% CI 1.316–19.339; p = 0.018) and then thirteen times (OR13.556; 95% CI 1.225–149.984; p = 0.034) respectively. Regarding surgical technique used, AEs occurred 97% less when Sleeve Resection was used relative to Dorsal Slit (OR 0.029; 95% CI 0.002–0.503; p = 0.038). The rest of the factors were not associated with AE, see Table 3 for more details.

Table 3. Factors associated with VMMC AE after univariate binomial regression.

OR (95% CI) P value
Age (years), n = 390 0.386
    18–49 years 1
    50+ years 2.55 (0.31–21.2)
Marital Status, n = 386 0.912
    Not Married 1
    Married 1.07 (0.32–3.63)
Tribe, n = 385 0.076
    Bemba 1
    Non-Bemba 6.46 (0.825–50.57)
Primary Indication for VMMC, n = 353 0.713
    Partial Protection against acquiring HIV 1
    Other 0.68 (0.09–5.42)
VMMC Volume, n = 391
    Enrolled Nurses (ZEN, ETN) 1 0.027
    Registered Nurses (RN, RTN, RM) 5.04 (1.32–19.34) 0.018
    Medical Officer (JRMO, Surgeon) 13.56 (1.23–149.98) 0.034
Date of operation via Quarter, n = 391 0.665
    January–June 1
    July–December 1.29 (0.40–4.15)
Duration, n = 347
    < 20 minutes 1 0.770
    20–30 minutes 1.04 (0.25–4.25) 0.957
    > 30 minutes 0.48 (0.05–4.69) 0.525
Local Anaesthetic amount used, n = 236 0.432
    Between 8–10 ml 1
    Below 8 or above 10 2.00 (0.36–11.26)
VMMC Type, n = 386 0.015
    Dorsal Slit 1
    Sleeve Resection 33.91 (1.99–578.02)
Follow-up visit at 48 hours, n = 391 0.527
    Yes 1
    No 0.51 (0.07–4.06)
Follow-up visit at 7 days, n = 391 0.827
    Yes 1
    No 0.88 (0.27–2.82)
Follow-up visit at 4 weeks, n = 391 0.099
    Yes 1
    No 0.35 (0.10–1.22)
Follow-up at least 1 visit post VMMC, n = 391 0.805
    Yes 1
    No 0.77 (0.10–6.13)

To control for confounders, multivariate binomial regression was used to model the association between AE and selected variables at p ≤ 0.05 which included VMMC volume and VMMC type (see Table 4). The regression model significantly (χ2 8.41, p = 0.015) accounted for the factors associated with AEs and this represented up to 8.9% of the factors affecting AEs (based on Nagelkerke R2). VMMC volume was the only factor significant and independently associated with adverse events. There was an inversely proportional relationship between VMMC volume and AEs as lower volumes were associated with more AEs. Compared to the highest VMMC volume of 63.2% (247/391), the odds of experiencing an adult VMMC AE was significantly increased by five times (aOR 5.08; 95% CI 1.33–19.49; p = 0.018) with a VMMC volume of 35.0% (137/391) and sixteen times (aOR 16.13; 95% CI 1.42–183.30; p = 0.025) with a VMMC volume of 1.8% (7/391) (see Table 4). In decreasing order of VMMC volume, enrolled nurses conducted the most (63.2%) followed by registered nurses (35.0%) and lastly medical officers (1.8%).

Table 4. Variables included in the multivariate analysis.

Multivariate Analysis
aOR (95% CI) P value
VMMC Volume, n = 391
    Enrolled Nurses (ZEN, ETN) 1 0.022
    Registered Nurses (RN, RTN, RM) 5.08 (1.33–19.49) 0.018
    Medical Officer (JRMO, Surgeon) 16.13 (1.42–183.30) 0.025

Discussion

Our study investigated the specific demand-side factors affecting the low VMMC coverage by focusing on the safety/quality of the VMMC program in Zambia. This was done by estimating the prevalence of VMMC adverse events among adult males and assessing associated factors in this group in Ndola city of Copperbelt Province, Zambia. We found that the estimated prevalence of VMMC AEs among adult males in Ndola city, Copperbelt Province was generally low (3.1%) and tended to be higher in the postoperative (2.6%) compared to the intraoperative period (0.5%). The prevalence of VMMC AEs in the intraoperative period of our study was slightly higher than the two prospective cohort studies done in Kenya and South Africa[10, 14]. This was probably attributed to VMMC providers with less surgical proficiency (i.e. Junior Resident Medical Officer) and the use of surgically advanced VMMC methods (i.e. Sleeve Resection) in less experienced clinician hands; this result must be interpreted with extreme caution because of the few numbers of Sleeve Resections done. To reduce AEs, WHO recommends the use Dorsal Slit as the surgical method of choice because of its safety, needing less theatre assistance, requiring less surgical expertise, easy to learn and gain proficiency [18]. Evidence from other cross-sectional studies have shown that the overall prevalence of VMMC AE is between 0.2% to 8.6%% which resonates with our studies results [1517]. Besides, more robust studies (i.e., prospective cohorts) in SSA have also established that the prevalence of VMMC AE ranged from 2.0% to 5.5% which is also consistent with our findings [1013]. The dissimilarity in prevalence may be caused by variability in sample sizes and study types (experimental versus observational).

Our study showed that there was a significant association between AE and the VMMC volume (as measured by the number of surgeries conducted per VMMC provider). There was an inversely proportional relationship between AE and VMMC volume because the more a provider performed circumcisions, experience increased and thus the less likely an adverse event would occur, the converse was also correct. In our study, most circumcisions were performed by enrolled nurses, then registered nurses and lastly medical officers. This study did not focus on the quality of surgical techniques necessary to compare AEs among the VMMC providers using a prospective cohort study. The AEs differences among VMMC providers is multifactorial and inclusive of differences in VMMC volume. All VMMC providers undergo standardised training and before being certified, must demonstrate surgical competence by performing a specified number of circumcisions under close supervision [9, 16]. However, to maintain the desired level of competence to gain surgical proficiency, the routine practice, especially after certification is recommended [9]. Despite all VMMC providers in our study being certified surgically competent, the surgically proficiency was questionable with very low frequency and number of VMMC conducted. Hence the differences in AE are probably because enrolled nurses gained the most surgical proficiency as they performed the majority of circumcisions (63.2%), followed by registered nurses (35.0%) and lastly medical officers (1.8%). These findings are similar to a prospective cohort study in Kenya which showed that VMMC providers (nurses and clinicians) who performed a large number of circumcisions gained surgical proficiency and were significantly less likely to cause adverse events [10].

There were differences in the types of VMMC AE experienced among studies during the postoperative follow-up visit. In our study, the frequency of commonly reported VMMC AEs postoperatively at the 48 hours follow-up visit were bleeding (4/8), swelling (2/8), and haematoma (2/8). Our findings are similar to a Zimbabwean cross-sectional study which reported that bleeding was the most common VMMC AE in the first 48 hours [20]. During the 7 days follow-up visit, the frequency of reported VMMC AEs were bleeding (3/7), swelling (3/7), and haematoma (1/7) in our study. In comparison, a South African prospective cohort study showed that swelling and wound infection were the most common VMMC AEs at 7 days [14]. In contrast to our study, a Malawian study reported more VMMC AEs which included in decreasing order infections, haematoma, swelling, delayed wound healing, bleeding, and wound disruption [15] while a retrospective case series analysis done in Tanzania reported that infection was the most common VMMC AE [16]. At the 4 weeks follow-up visit, our study showed that one participant experienced delayed wound healing. In comparison, a South African prospective cohort study reported mostly infection, and some swelling accounted for the bulk of the AE experienced [14]. Variation in results among studies may be due to differences in schedules used for postoperative follow-up visits, and differences in AE reporting guidelines. Furthermore, our study showed that there was no significant association between AE and those who attended at least one follow-up visit.

Lastly, our study’s VMMC AE from surgical techniques when compared with AE from medical devices such as prepex was slightly higher by 1.01%. This is because a 2016 prospective cohort pilot study done in three countries (Mozambique, South Africa, and Zambia) showed that prevalence of AE after use of prepex was 2.0% in Zambia [21]. Furthermore, a 2016 local randomised controlled trial showed that the prevalence of AE after shang ring use was much lower at 0.6%. Differences in AE among VMMC methods are multifactorial and may include short procedure time, less surgical skill needed, and improved safety profile [22, 23]. Despite the lower prevalence of AE with medical devices, the majority of VMMC in Zambia are still via conventional surgery not device based. This is because of the gradual transition from research findings to clinical implementation, lack of standard operating procedures for shang ring till May 2020 [24] and higher overall costs [22, 23].

At the national level, our study contributes to Zambia’s Ministry of Health legacy goal number 6, which aims to achieve HIV epidemic control by reducing the HIV incidence from 48,000 to 5,000. This study also provides high priority national and regional information on VMMC policy monitoring and evaluation with regards to VMMC quality (AE), surgical efficiency (VMMC surgical methods), and human resource (VMMC providers). At both national and regional level, this study confirms that the quality of the VMMC program in Ndola city, Copperbelt Province of Zambia is adequate owing to the high safety profile as evidenced by the low prevalence of VMMC AEs below 5%. At a global level, this study contributes to sustainable development goal number 3, which aims to end the AIDS epidemic by 2030.

This study had a few potential limitations. The minor change in reporting format on the VMMC client record form under demographics (i.e., marital status) occurred in the second part of 2015 could have led to bias; however, this was accounted for during coding in SPSS. This study was conducted from one tertiary hospital to represent the provincial level; hence results should be cautiously interpreted and generalised at the country level. There was incomplete or missing information in the VMMC client record form which was handled during the statistical analysis. Overall the use of secondary data for research limits the researcher as the data is not meant for research purposes.

Conclusion

The low prevalence of AE guarantees the safety of the VMMC program in Ndola city, Copperbelt Province of Zambia. The VMMC volume was significantly associated with AEs. Therefore, adult circumcisions were safer when VMMC providers regularly performed more circumcisions (thus gained more surgical proficiency) than those who did not. Considering alternative factors affecting VMMC coverage there is also a need to explore other national and high priority areas of VMMC program quality such as adherence to follow-up visits client satisfaction, and counselling services.

Supporting information

S1 Data

(SAV)

Acknowledgments

We wish to acknowledge the invaluable support received from the Ndola Teaching Hospital Management and specifically the Male Circumcision providers for their technical support during the study. We thank Dr Gavin George and the entire management at the school of health sciences, Kwazulu-Natal University for making this work possible.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) did not receive any funding for this work.

References

  • 1.WHO. Voluntary medical male circumcision for HIV prevention. [Internet]. 2012 [cited 2015 September 26]. Available from: http://www.who.int/hiv/topics/malecircumcision/fact_sheet/en/.
  • 2.WHO/UNAIDS. Male circumcision: global trends and determinants of prevalence, safety and acceptability. Geneva: WHO Press; 2007. [Google Scholar]
  • 3.Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk. [Internet]. 2005 [cited 2015 September 3]. Available from: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020298. [DOI] [PMC free article] [PubMed]
  • 4.Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–56. doi: 10.1016/S0140-6736(07)60312-2 [DOI] [PubMed] [Google Scholar]
  • 5.Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–666. doi: 10.1016/S0140-6736(07)60313-4 [DOI] [PubMed] [Google Scholar]
  • 6.Gray RH, Kigozi G, Kong X, Ssempiija V, Makumbi F, Wattya S, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a post-trial follow up study in Rakai, Uganda. AIDS. 2012;26(5):609–615. doi: 10.1097/QAD.0b013e3283504a3f [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Uthman OA, Popoola TA, Uthman MM, Aremu O. Economic Evaluations of Adult Male Circumcision for Prevention of Heterosexual Acquisition of HIV in Men in Sub-Saharan Africa: A Systematic Review. PLos ONE. 2010;5(3):1371. doi: 10.1371/journal.pone.0009628 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.GRZ. Zambia Demographic and Health Survey 2018. [Internet]. 2018 [cited 2020 September 10]. Available from: https://dhsprogram.com/pubs/pdf/FR361/FR361.pdf.
  • 9.WHO. Preventing HIV through safe voluntary medical male circumcision for adolescent boys and men in generalized HIV epidemics: recommendations and key considerations. [Internet]. Geneva: World Health Organisation; 2020 [cited 2020 September 10]. Available from: https://www.who.int/publications/i/item/978-92-4-000854-0. [PubMed]
  • 10.Herman-Roloff A, Bailey RC, Agot K. Factors associated with the safety of voluntary medical male circumcision in Nyanza province, Kenya. Bull World Health Organ. 2012;90:773–781. doi: 10.2471/BLT.12.106112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Frajzyngier V, Odingo G, Barone M, Perchal P, Pavin M. Safety of adult medical male circumcision performed by non-physician clinicians in Kenya: a prospective cohort study. Global Health: Science and Practice. 2014;4(1):93–102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Matumaini HK, Batte A, Otwombe K, Lebotsa E, Luboga S. Outcomes of male circumcision performed by medical doctors and non–doctor health workers in central Uganda. [Internet]. 2014 [cited 2020 August 13]. Available from: http://makir.mak.ac.ug/handle/10570/4367.
  • 13.Reed J, Grund JM, Liu Y, Mwandi ZL. Evaluation of Loss-to-Follow-up and Postoperative Adverse Events in a Voluntary Medical Male Circumcision Program in Nyanza Province, Kenya. Acquir Immune Defic Syndr. 2015;69(1):e13–e26. [DOI] [PubMed] [Google Scholar]
  • 14.Phili R, Abdool-Karim Q, Ngesa O. Low adverse event rates following voluntary medical male circumcision in a high HIV disease burden public sector prevention programme in South Africa. Journal of the International AIDS Society. 2014;17(19275):1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.WHO. Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men. [Internet]. 2018 [cited 2020 August 08]. Available from: https://apps.who.int/iris/bitstream/handle/10665/272387/9789241513593-eng.pdf?ua=1.
  • 16.GRZ. Zambia National VMMC Operational Plan (2016–2020). [Internet]. Lusaka: Government printers; 2016 [cited 2020 August 09]. Available from: http://dspace.unza.zm/bitstream/handle/123456789/5108/ZambiaVMMCoperationalPlan2016-2020(1).pdf;jsessionid=FDD56C481EBADD5111AA97235A551930?sequence=1.
  • 17.GRZ. The 2012 List of Health Facilities in Zambia. [Internet]. 2012 [cited 2016 February 11]. Available from: http://www.moh.gov.zm/docs/facilities.pdf.
  • 18.Kohler PK, Namate D, Barnhart S, Chimbwandira F, Tippet-Barr BA, Perdue T, et al. Classification and rates of adverse events in a Malawi male circumcision program: impact of quality improvement training. BMC Health Services Research. 2016;16(61):1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kang H. The prevention and handling of the missing data. Korean J Anesthesiol. 2013;64(5):402–406. doi: 10.4097/kjae.2013.64.5.402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Feldacker C, Bochner AF, Murenje V, Makunike-Chikwinya B, Holec M, Xaba S, et al. Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe. PLoS ONE. 2018;13(9):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Feldblum P, Martinson N, Bvulani B, Taruberekera N, Mahomed M, Chintu N, et al. Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia. J Acquir Immune Defic Syndr. 2016;72:S43–S48. doi: 10.1097/QAI.0000000000000742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bratt JH, Zyambo Z. Comparing direct costs of facility-based Shang Ring provision versus a standard surgical technique for voluntary medical male circumcision in Zambia. J Acquir Immune Defic Syndr. 2013;63(3):e109–e112. doi: 10.1097/QAI.0b013e31828e9526 [DOI] [PubMed] [Google Scholar]
  • 23.Vandament L, Chintu N, Yano N, Mugurungi O, Xaba S, Mpasela F, et al. Evaluating Opportunities for Achieving Cost Efficiencies Through the Introduction of PrePex Device Male Circumcision in Adult VMMC Programs in Zambia and Zimbabwe. J Acquir Immune Defic Syndr. 2016;72(Supp1):S90–S95. doi: 10.1097/QAI.0000000000000722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.GRZ/MOH. Shang Ring Device for Voluntary Medical Male Circumcision. [Internet]. 2020 [cited 2021 April 20]. Available from: https://www.moh.gov.zm/?wpfb_dl=166.

Decision Letter 0

Richard Kao Lee

8 Mar 2021

PONE-D-20-40949

Prevalence and correlates of voluntary medical male circumcision adverse events among adult males in the Copperbelt Province of Zambia: a cross-sectional study

PLOS ONE

Dear Dr. Daka,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Richard Kao Lee, M.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

3.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Additional Editor Comments:

No major new findings outside of surgical volume-outcomes relationship which has been previously described

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors performed a descriptive study of the AEs that were seen in a VMMC program in Ndola city of Zambia. Please see my comments below:

Introduction –

1. Line 66: key intervention for what? Please delete or edit this sentence.

2. Introduction is too long with multiple points that should be in discussion. The authors should provide a short description of the current problems of VMMC in Africa and then mention why their study is of importance. Most of the introduction points should be moved to discussion.

Methods –

1. Authors should report patient comorbidities that could be a reason of AEs

2. The MV analysis should be performed including patient comorbidities, VMMC type and timing of AE.

Discussion –

1. The authors should discuss how their AEs compare to studies using medical devices (Mogen clamp, ShangRing etc). WHO has approved many of these devices to promote circumcisions in Africa so a comparison should be made.

Reviewer #2: Reviewer Recommendation and Comments for Manuscript Number PONE-D-20-40949

Prevalence and correlates of voluntary medical male circumcision adverse events among adult males in the Copperbelt Province of Zambia: a cross-sectional study

Comments to author:

The authors have performed a cross-sectional study of prevalence of VMMC AE and their associated factors among adult males in Ndola, Zambia. This type of study is important to inform program quality and safety. The authors found a low prevalence of AEs, providing assurance that VMMC’s conducted at the study site are safe.

I am concerned as you will see in the comments below about the conclusion related to volume of procedures conducted and occurrence of AEs. While I don’t take issue with the fact that it is likely (and there are data from other’s studies showing this) that providers who conducted larger numbers of procedures had fewer AEs, I don’t think you can make this conclusion based on how the data are presented. The issue is that you have not looked at the numbers of AEs resulting from VMMCs conducted by INDIVIDUAL providers, but rather by TYPES of providers. There is no indication of how many providers are in each of the three groups or how many procedures any given provide performed. The results could be heavily biased if say one or two providers performed a large number of all the procedures or if most of the AEs occurred following VMMCs by one or two providers. If you can present results showing how many providers are in each group, the range of VMMCs performed by providers in each group and the range of AEs/provider that may make the conclusion more appropriate. I also question the inclusion of the medical offices who only conducted 7 VMMCs and the analyses looking at sleeve resection given that there were only 2 cases.

The authors should address the comments below and submit a revised version of the manuscript before the journal makes a decision. My comments are listed by line number in the PDF version of the manuscript.

Lines 75 & 76. Could the authors please clarify the statement about circumcision in Northern Africa. The term VMMC has generally been applied to the male circumcision services provided in medical settings related to HIV prevention (in fact it was not even in use to my knowledge until the establishment of the male circumcision interventions in sub-Saharan Africa beginning in 2008-2009). It thus seems inaccurate to say that VMMC is practiced extensively in Northern Africa. Are the authors referring to common occurrence of traditional circumcision for cultural or religious reasons, for example? Please clarify.

Lines 84 85. Please add that the AE rates being quotes are from various countries in sub-Saharan Africa.

Lines 101-102. The authors indicate that one of the main WHO monitoring and evaluation parameters is the number or percentage of circumcised males experiencing and adverse event during the VMMC, but I think they mean during and after.

Line 127. In the study design section, I think it would be useful to the reader to include what type of VMMC procedure(s) are used at the facility and also what follow-up schedule is used.

Line 132. Please add some additional text that explains what adopting a “campaign VMMC model” means.

Line 133. Please clarify what the seven core VMMC responsibilities are. I don’t think the average reader will understand what this means.

Line 166. Could the authors provide the reason that an ERC from South Africa was used for the study in Zambia. All of the authors of the paper are from Zambian institutions, so it seems unusual and would be good to indicate the reason.

Line 183-185. Please clarify if the exclusion was just for the variable(s) that was missing as opposed to excluding the entire form/participant.

Line 186. It might be clearer if the first section in the results is titled Adverse Events. That section could include the sentences that are on line 188-194 as that information doesn’t relate to socio-demographic characteristics.

Line 198. Please add the percentage to match the way other results are reported. Also, to reduce any confusion it might be better to say 50 + years since that is the way the results are presented in the table.

Line 201. Please add that the partial protection being referred to here (and add to the table as well) is for HIV.

Lines 201-203. It is misleading to say that the AEs were higher in those undergoing VMMC for partial protection when in fact the difference was not significant. The numerical difference is small and also the number in the “other” group is small.

Line 214 & 222. I think it would be clearer to talk about volume/cadre as opposed to just volume.

Line 217. Please add the percentage.

Lines 228 & 229. The abbreviations are confusing and don't match what is in the table. Is a registered midwife, considered a registered nurse? If not then in the table and text it would be better to have Registered nurse/midwives.

Table 2.

• Says Date of operation via Quarter, but the data are for half the year, not by quarters. The term semester is used in the text.

• Also, please check the *. I think that in two cases there is one, when there should be two (type of VMMC and follow-up visit immediately post op).

• “Follow-up visit immediately post op” Please remove the word visit assuming this is during the post-op period before they have left the facility it is confusing to use the word visit.

• I am afraid I don’t understand what the yes and no rows for the follow-up visit variables mean. If it means yes they came for a visit and no they didn’t, then how do you know if they had an AE if they didn’t come for that visit? Somehow this needs to be clarified. The same issue applies to table 3.

Lines 236-238. I find the issue of volume as related to likelihood of AEs to be confusing and I am not sure how to interpret the results. When I read the abstract, I was under the impressions that volume related to an individual provider, i.e. those individuals who had performed more VMMC, had fewer AEs. The text in the abstract is “VMMC volume (as measured by the number of surgeries conducted per VMMC provider”), which I think suggests volume relates to an individual provider. That same text appears here on line 237 & 238 (and 286 & 287). However, from looking at the data in Table 2, it seems that volume is related to a TYPE of provider (i.e., Enrolled Nurses vs. Registered Nurses vs. Medical Officers) and not an INDIVIDUAL provider as suggested by the text in the abstract, results, and discussion.

I am not sure how one interprets the results when they are presented this way because we don’t know how many providers there were in each of the type of providers (how many enrolled nurses, how many registered nurses, how many medical officers), how many VMMCs were done by each provider, and only 1.8% of all the VMMCs were done by medical officers. Maybe, for example, the medical officer was called in to do difficult cases.

Lines 242-244. I am not a statistician, but it seems questionable to me, irrespective of what the statistical testing shows, to make statement about the effect of VMMC technique on occurrence of AE’s when there were only two cases of sleeve resection

Lines 273-277. There is nothing in the results to indicate what VMMC procedure was done in the 2 AEs that occurred during the operation, but based on the text here it seems that the 1 AE reported intra-op was in a sleeve resection. I think it would be useful to put this information in the results. I wonder about the conclusion that this slightly higher rates of intraop AE was “probably attributed to VMMC providers with less surgical proficiency and the use of surgically advanced VMMC methods (i.e. Sleeve Resection) in less experienced clinician hands”. Is there some information to substantiate that the providers who did the sleeve resections were less experienced or less surgically proficient?”

Lines 292-295. “This study did not focus on the quality of surgical techniques necessary to compare AEs among the VMMC providers using a prospective cohort study. Hence, AEs differences among VMMC providers is probably due to differences in VMMC volume.” I am not sure what the first sentence means here and also that just because you didn’t focus on the quality doesn’t mean the difference isn’t due to the quality.

Lines 299-301. I don’t think it is appropriate to make the following statement: “Despite all VMMC providers in our study being certified surgically competent, few were surgically proficient as evidenced by the frequency and number of VMMC conducted.” There are no data presented on frequency or number provided by individual providers on which to base that statement.

Lines 301-307. Again, the conclusions don’t really follow from the data. The study in Kenya that is quoted look at numbers of VMMC conducted by individual providers, not types of providers and so it was appropriate for them to conclude that those conducting more procedures had fewer AEs. Here, however, without knowing how many providers there are in each of the three groups or how many procedures different providers performed, I don’t believe you can make these conclusions. Perhaps there were one or two provider who performed most of the procedures in one of the nurse group who were either more or less skilled and perhaps a less skilled provider was responsible for most of the AES. Or as noted above, perhaps the medical officers were called for difficult cases and that is why it seems their AE rate was high.

Lines 341-343. I don’t recall any mention of a change in the form in the methods. Please clarify there or here what that change was.

For Figure 2, please indicate how many men/records there were for the follow-up visits at the three time points. The reader will wonder if all men had data for all of the follow-up visits.

Reviewer #3: Excellent and well thought out manuscript with rigorously executed methodology. Good addition to the literature on safety of VMMC in Sub-Saharan Africa. I would only suggest the authors consider describing AE severity distributions (total and by providers). Authors should also consider reporting how the degree of severity was determined (individual provider? consensus?) The manuscript may also benefit from a statement providing more details on the post-operative AE collection mechanisms: did patient have the possibility to call their providers re: AEs outside of study visits? If so, were those calls systematically captured using one of the collected forms? Also, while AEs beyond six weeks post VMMC have been rare, how long after the procedure would a patient's report of VMMC-related AE would have been recorded? Beyond this minor modifications, I look forward to seeing this manuscript published.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Quincy Nang, MD, MPH

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Sep 3;16(9):e0256955. doi: 10.1371/journal.pone.0256955.r002

Author response to Decision Letter 0


14 Jun 2021

RESPONSE TO REVIEWERS

Reviewer #1: The authors performed a descriptive study of the AEs that were seen in a VMMC program in Ndola city of Zambia. Please see my comments below:

Introduction –

1. Line 66: key intervention for what? Please delete or edit this sentence.

Response: We have revised as suggested

2. Introduction is too long with multiple points that should be in discussion. The authors should provide a short description of the current problems of VMMC in Africa and then mention why their study is of importance. Most of the introduction points should be moved to discussion.

Response: We revised as suggested.

Methods –

1. Authors should report patient comorbidities that could be a reason of AEs

2. The MV analysis should be performed including patient comorbidities, VMMC type and timing of AE.

Response: Noted, these data were not available for analysis and therefore was not included in the MV analysis.

Discussion –

1. The authors should discuss how their AEs compare to studies using medical devices (Mogen clamp, ShangRing etc.). WHO has approved many of these devices to promote circumcisions in Africa so a comparison should be made.

Response: We revised as suggested

Reviewer #2: Reviewer Recommendation and Comments for Manuscript Number PONE-D-20-40949

Prevalence and correlates of voluntary medical male circumcision adverse events among adult males in the Copperbelt Province of Zambia: a cross-sectional study

Comments to author:

The authors have performed a cross-sectional study of prevalence of VMMC AE and their associated factors among adult males in Ndola, Zambia. This type of study is important to inform program quality and safety. The authors found a low prevalence of AEs, providing assurance that VMMC’s conducted at the study site are safe.

I am concerned as you will see in the comments below about the conclusion related to volume of procedures conducted and occurrence of AEs. While I don’t take issue with the fact that it is likely (and there are data from other’s studies showing this) that providers who conducted larger numbers of procedures had fewer AEs, I don’t think you can make this conclusion based on how the data are presented. The issue is that you have not looked at the numbers of AEs resulting from VMMCs conducted by INDIVIDUAL providers, but rather by TYPES of providers. There is no indication of how many providers are in each of the three groups or how many procedures any given provide performed. The results could be heavily biased if say one or two providers performed a large number of all the procedures or if most of the AEs occurred following VMMCs by one or two providers. If you can present results showing how many providers are in each group, the range of VMMCs performed by providers in each group and the range of AEs/provider that may make the conclusion more appropriate. I also question the inclusion of the medical offices who only conducted 7 VMMCs and the analyses looking at sleeve resection given that there were only 2 cases.

The authors should address the comments below and submit a revised version of the manuscript before the journal makes a decision. My comments are listed by line number in the PDF version of the manuscript.

Lines 75 & 76. Could the authors please clarify the statement about circumcision in Northern Africa. The term VMMC has generally been applied to the male circumcision services provided in medical settings related to HIV prevention (in fact it was not even in use to my knowledge until the establishment of the male circumcision interventions in sub-Saharan Africa beginning in 2008-2009). It thus seems inaccurate to say that VMMC is practiced extensively in Northern Africa. Are the authors referring to common occurrence of traditional circumcision for cultural or religious reasons, for example? Please clarify.

Response: Noted, we revised as suggested

Lines 84 85. Please add that the AE rates being quotes are from various countries in sub-Saharan Africa.

Response: We revised as suggested

Lines 101-102. The authors indicate that one of the main WHO monitoring and evaluation parameters is the number or percentage of circumcised males experiencing and adverse event during the VMMC, but I think they mean during and after.

Response: Noted, we revised as suggested

Line 127. In the study design section, I think it would be useful to the reader to include what type of VMMC procedure(s) are used at the facility and also what follow-up schedule is used.

Response: We revised as suggested

Line 132. Please add some additional text that explains what adopting a “campaign VMMC model” means.

Response: Addition made as suggested

Line 133. Please clarify what the seven core VMMC responsibilities are. I don’t think the average reader will understand what this means.

Response: Clarification made as suggested

Line 166. Could the authors provide the reason that an ERC from South Africa was used for the study in Zambia. All of the authors of the paper are from Zambian institutions, so it seems unusual and would be good to indicate the reason.

Response: At the time of the study the principal and first author was based and affiliated to University of KwaZulu Natal.

Line 183-185. Please clarify if the exclusion was just for the variable(s) that was missing as opposed to excluding the entire form/participant.

Response: We revised as advised

Line 186. It might be clearer if the first section in the results is titled Adverse Events. That section could include the sentences that are on line 188-194 as that information doesn’t relate to socio-demographic characteristics.

Response: We revised as advised

Line 198. Please add the percentage to match the way other results are reported. Also, to reduce any confusion it might be better to say 50 + years since that is the way the results are presented in the table.

Response: We revised as advised

Line 201. Please add that the partial protection being referred to here (and add to the table as well) is for HIV.

Response: We revised as advised

Lines 201-203. It is misleading to say that the AEs were higher in those undergoing VMMC for partial protection when in fact the difference was not significant. The numerical difference is small and also the number in the “other” group is small.

Response: We revised as advised

Line 214 & 222. I think it would be clearer to talk about volume/cadre as opposed to just volume.

Response: Noted, with the advent of task shifting, the study focus was on volume. Furthermore 98.2% (384/391) of VMMC was performed by nurses

Line 217. Please add the percentage.

Response: Added as advised

Lines 228 & 229. The abbreviations are confusing and don't match what is in the table. Is a registered midwife, considered a registered nurse? If not then in the table and text it would be better to have Registered nurse/midwives.

Response: Adjusted as advised, registered nurses (i.e. diploma holders) can have no specialty i.e. registered general nurse or with theater specialty i.e. registered theater nurse or with obstetric specialty i.e. registered midwife

Table 2.

• Says Date of operation via Quarter, but the data are for half the year, not by quarters. The term semester is used in the text.

• Also, please check the *. I think that in two cases there is one, when there should be two (type of VMMC and follow-up visit immediately post op).

• “Follow-up visit immediately post op” Please remove the word visit assuming this is during the post-op period before they have left the facility it is confusing to use the word visit.

• I am afraid I don’t understand what the yes and no rows for the follow-up visit variables mean. If it means yes they came for a visit and no they didn’t, then how do you know if they had an AE if they didn’t come for that visit? Somehow this needs to be clarified. The same issue applies to table 3.

Response: Revised as advised. No means absconded follow-up visit. Retrospective data was used, adverse effects in the those who didn’t attend follow-up visits were not assessed and handled as missing variables in the statistical analysis.

Lines 236-238. I find the issue of volume as related to likelihood of AEs to be confusing and I am not sure how to interpret the results. When I read the abstract, I was under the impressions that volume related to an individual provider, i.e. those individuals who had performed more VMMC, had fewer AEs. The text in the abstract is “VMMC volume (as measured by the number of surgeries conducted per VMMC provider”), which I think suggests volume relates to an individual provider. That same text appears here on line 237 & 238 (and 286 & 287). However, from looking at the data in Table 2, it seems that volume is related to a TYPE of provider (i.e., Enrolled Nurses vs. Registered Nurses vs. Medical Officers) and not an INDIVIDUAL provider as suggested by the text in the abstract, results, and discussion.

I am not sure how one interprets the results when they are presented this way because we don’t know how many providers there were in each of the type of providers (how many enrolled nurses, how many registered nurses, how many medical officers), how many VMMCs were done by each provider, and only 1.8% of all the VMMCs were done by medical officers. Maybe, for example, the medical officer was called in to do difficult cases.

Response: Table 2 shows that enrolled nurses performed 63.2% (247/391) VMMC’s, registered nurses 35.0% (137/391) and medical officers 1.8% (7/391)

Lines 242-244. I am not a statistician, but it seems questionable to me, irrespective of what the statistical testing shows, to make statement about the effect of VMMC technique on occurrence of AE’s when there were only two cases of sleeve resection

Response: Noted, however, there is also a disclaimer that the “result must be interpreted with extreme caution because of the few numbers of Sleeve Resections done”

Lines 273-277. There is nothing in the results to indicate what VMMC procedure was done in the 2 AEs that occurred during the operation, but based on the text here it seems that the 1 AE reported intra-op was in a sleeve resection. I think it would be useful to put this information in the results. I wonder about the conclusion that this slightly higher rates of intraop AE was “probably attributed to VMMC providers with less surgical proficiency and the use of surgically advanced VMMC methods (i.e. Sleeve Resection) in less experienced clinician hands”. Is there some information to substantiate that the providers who did the sleeve resections were less experienced or less surgically proficient?”

Response: We reviewed as advised, a Junior Resident Medical Officer (also called an intern doctor) performed the sleeve resection.

Lines 292-295. “This study did not focus on the quality of surgical techniques necessary to compare AEs among the VMMC providers using a prospective cohort study. Hence, AEs differences among VMMC providers is probably due to differences in VMMC volume.” I am not sure what the first sentence means here and also that just because you didn’t focus on the quality doesn’t mean the difference isn’t due to the quality.

Response: we revised as advised

Lines 299-301. I don’t think it is appropriate to make the following statement: “Despite all VMMC providers in our study being certified surgically competent, few were surgically proficient as evidenced by the frequency and number of VMMC conducted.” There are no data presented on frequency or number provided by individual providers on which to base that statement.

Response: We revised as advised

Lines 301-307. Again, the conclusions don’t really follow from the data. The study in Kenya that is quoted look at numbers of VMMC conducted by individual providers, not types of providers and so it was appropriate for them to conclude that those conducting more procedures had fewer AEs. Here, however, without knowing how many providers there are in each of the three groups or how many procedures different providers performed, I don’t believe you can make these conclusions. Perhaps there were one or two provider who performed most of the procedures in one of the nurse group who were either more or less skilled and perhaps a less skilled provider was responsible for most of the AES. Or as noted above, perhaps the medical officers were called for difficult cases and that is why it seems their AE rate was high.

Response: Revised as advised under “VMMC operation details” first paragraph. VMMC’s were done by 7 individual providers throughout the year 2015. More than half (63.2%) of them were by two individuals enrolled nurses, 35% by three individuals registered nurses and 1.8% by two individual medical officers

Lines 341-343. I don’t recall any mention of a change in the form in the methods. Please clarify there or here what that change was.

Response: We revised as advised

For Figure 2, please indicate how many men/records there were for the follow-up visits at the three time points. The reader will wonder if all men had data for all of the follow-up visits.

Response: The information of total men/records is also provided in table 2 to avoid overcrowding of data

Reviewer #3: Excellent and well thought out manuscript with rigorously executed methodology. Good addition to the literature on safety of VMMC in Sub-Saharan Africa. I would only suggest the authors consider describing AE severity distributions (total and by providers). Authors should also consider reporting how the degree of severity was determined (individual provider? consensus?) The manuscript may also benefit from a statement providing more details on the post-operative AE collection mechanisms: did patient have the possibility to call their providers re: AEs outside of study visits? If so, were those calls systematically captured using one of the collected forms? Also, while AEs beyond six weeks post VMMC have been rare, how long after the procedure would a patient's report of VMMC-related AE would have been recorded? Beyond this minor modifications, I look forward to seeing this manuscript published.

Response: Noted, data on AE severity were not available for analysis. Retrospective data from hospital records were used and there was no evidence of active follow-up of post-operative AE using phone calls. Individuals with AE who presented themselves to the hospital had the AE’s recorded

Decision Letter 1

Richard Kao Lee

20 Aug 2021

Prevalence and correlates of voluntary medical male circumcision adverse events among adult males in the Copperbelt Province of Zambia: a cross-sectional study

PONE-D-20-40949R1

Dear Dr. Daka,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Richard Kao Lee, M.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors performed a descriptive study of the AEs that were seen in a VMMC program in Ndola city of Zambia. The authors have adequately addressed all the comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Richard Kao Lee

27 Aug 2021

PONE-D-20-40949R1

Prevalence and correlates of voluntary medical male circumcision adverse events among adult males in the Copperbelt Province of Zambia: a cross-sectional study

Dear Dr. Daka:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Richard Kao Lee

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (SAV)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES